SL
GSK icon

Savior LLC’s GSK GSK Stock Holding History

Savior LLC’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-330
Closed -$16K – 430
2021
Q2 		$16K Hold
330
– – 0.01% 321
2021
Q1 		$15K Sell
330
-137
-29% -$6.22K 0.02% 333
2020
Q4 		$21K Hold
467
– – 0.02% 279
2020
Q3 		$22K Hold
467
– – 0.03% 238
2020
Q2 		$24K Sell
467
-48
-9% -$2.46K 0.03% 207
2020
Q1 		$24K Hold
515
– – 0.03% 179
2019
Q4 		$30K Buy
+515
New +$28.6K 0.04% 217

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Savior LLC's GSK Position: Q3 2021 in Review

Savior LLC sold out of GSK (GSK) in Q3 2021, closing a stake of 330 shares — an estimated $16K sold.

Savior LLC first reported a position in GSK in Q4 2019 and held it in 7 quarters. The position peaked at $30K in Q4 2019. 792 funds tracked by Wall St. Rank hold GSK as of Q3 2021.

  • Savior LLC reported no remaining GSK position as of Q3 2021 after selling out during the quarter.
  • Savior LLC sold 330 GSK shares in Q3 2021, an estimated $16K.
  • Savior LLC first reported a position in GSK in Q4 2019 and held it in 7 quarters.
  • Savior LLC's GSK position peaked at $30K in Q4 2019.
  • 792 funds tracked by Wall St. Rank held GSK as of Q3 2021.

Based on Savior LLC's 13F filing for Q3 2021, filed 5 Oct 2021.